ANDA pharma litigation spikes back up in 2017
After a slump in 2016, US pharmaceutical patent litigation triggered by the Hatch-Waxman process rose to 411 cases last year
Last year 411 ANDA cases were filed in the US, up from 318
in 2016, reveals Lex Machina’s recently released Patent
Litigation Year in Review report.
This meant ANDA litigation moved closer to the peak levels
seen in 2014...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.